<DOC>
	<DOCNO>NCT02583438</DOCNO>
	<brief_summary>The intestinal microflora imbalance associate obesity type 2 diabetes . The researcher ' study aim investigate effect saxagliptin gut microbiota patient newly diagnose type 2 diabetes .</brief_summary>
	<brief_title>Evaluate Effect Saxagliptin Gut Microbiota Patients With Newly Diagnosed Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Females male , age 20 65 year . Newly diagnose type 2 diabetes HbA1C ≥7 % HbA1C ＜9 % Hepatic insufficiency ( ALT AST &gt; 1.5*ULN ) Renal insufficiency [ Creatinine clearance rate ( Ccr ) ] &lt; 60ml/min estimate MDRD equation ) Coronary artery disease Thyroid disease Infectious disease Systemic inflammatory disease Cancer Subjects take agent know influence gut microbiota Pregnant lactate woman Other condition investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Gut Microbiota</keyword>
	<keyword>inflammatory marker</keyword>
	<keyword>Glucose lipid metabolism</keyword>
</DOC>